DCF — RIVERVIEW MEDICAL CENTER
Enterprise Value: $139.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$139.2M
Enterprise Value
$31.6M
PV of Cash Flows
$107.6M
PV of Terminal Value
$173.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $376.4M | $22.8M | 6.0% | $3.5M | $3.2M |
| Year 2 | $387.7M | $27.3M | 7.0% | $6.5M | $5.4M |
| Year 3 | $399.3M | $32.2M | 8.0% | $9.7M | $7.3M |
| Year 4 | $411.3M | $35.2M | 9.0% | $11.5M | $7.9M |
| Year 5 | $423.6M | $37.3M | 9.0% | $12.7M | $7.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $139.2M. Terminal value accounts for 77% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$365.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.055521893145748714
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5